Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06469918 · ClinicalTrials.gov registry record

The Co-Op @ HeartWorks

A clinical trial of Congenital Heart Disease, sponsored by HeartWorks.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT06469918: Recruiting study of Congenital Heart Disease, sponsored by HeartWorks.

NCT06469918 is a study of Congenital Heart Disease that is actively recruiting participants, run by HeartWorks. The registered enrollment target is 500 participants, roughly in line with the 466-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06469918, a study of Congenital Heart Disease, is actively recruiting participants, sponsored by HeartWorks.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

This protocol is a research study involving human subjects diagnosed with Congenital Heart Defects/Disease (CHD). The Co-Op @ HeartWorks is a cooperative between the research platform at HeartWorks and members of the CHD community. Individuals choosing to participate will be referred to as 'members' of the co-op. This study aims to create a database of members medical journey data to inform future clinical innovation and design of clinical trials which address the needs of the members. The knowledge generated from this study will help advance the care of CHD patients through the deliberate action of The Co-Op @ HeartWorks members. Unlike a traditional disease registry, the members of The Co-Op @ HeartWorks will actively inform and contribute to the future studies affecting their health.

Conditions Studied

Congenital Heart Disease

Study Locations (1)

Minnesota

  • HeartWorks, Inc. - Rochester

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2024-01-24
Est. Completion 2050-01-01
HeartWorks

3 total trials

What NCT06469918 shows while recruiting

NCT06469918 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 466-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target.

The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 0 interventions.

NCT06469918 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06469918 about?

NCT06469918 is a clinical study titled "The Co-Op @ HeartWorks". This protocol is a research study involving human subjects diagnosed with Congenital Heart Defects/Disease (CHD). The Co-Op @ HeartWorks is a cooperative between the research platform at HeartWorks and members of the CHD community. Individuals choosing to participate will be referred to as 'members'...

What is the current status of trial NCT06469918?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-01-24. Estimated completion is 2050-01-01.

What conditions does trial NCT06469918 study?

This clinical trial studies the following conditions: Congenital Heart Disease.

Who is sponsoring clinical trial NCT06469918?

This trial is sponsored by HeartWorks, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06469918 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Congenital Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06469918's enrollment target sits among peer trials

500 8th of 63 higher than 56 of 63 other Congenital Heart Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06469918

Source: ClinicalTrials.gov NCT06469918, the US trial registry maintained by the National Library of Medicine. NCT06469918 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.